World Ophthalmic Pharmaceutical Drugs Market

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • September 2014
  • 135 pages

BMI View: Despite the threat of austerity measures, the government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the patent cliff, we expect Germany to remain attractive to innovative drugmakers. Furthermore, per-capita ...

Industries: Drug and Medication | Countries: Germany

Alopecia - Pipeline Review, H2 2014

Alopecia - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • August 2014
  • 78 pages

Alopecia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Alopecia - Pipeline Review, H2 2014', provides an overview of the Alopecia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Alopecia, complete with comparative analysis at ...

Industries: Pathology | Countries: World, Germany

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • August 2014
  • 43 pages

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part of the very small tubes in the kidney that transport waste molecules from the blood to the urine. ...

Industries: Pathology | Countries: Japan, China, World, United States, Spain, Italy, France, Germany

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

Aesica Pharmaceuticals Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • by Global Data
  • August 2014
  • 30 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmaceutical | Countries: Italy, Germany, China, Switzerland, Austria, Europe, United States, United Kingdom

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

Andreae-Noris Zahn AG (Symbol:ANZ) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Andreae-Noris Zahn AG SWOT Analysis report provides you a strategic ...

Industries: Generic Drug | Countries: Germany

biolitec AG (Symbol:BIB) SWOT Analysis, Strategy, Revenues and Profits

biolitec AG (Symbol:BIB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. biolitec AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Germany, United States, Spain, Russian Federation, Italy

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

PHOENIX Group SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pharmacies and Drug Stores | Countries: Europe, Czech Republic, Germany, Sweden, Slovakia (slovak Republic), Italy, Finland, Denmark, Bulgaria, World, Switzerland, Netherlands, Norway, Hungary, Croatia, Bosnia and Herzegovina, Serbia and Montenegro

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

Recordati S.p.A. (Symbol:REC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Recordati S.p.A. SWOT Analysis report provides you a strategic analysis ...

Industries: Pharmaceutical | Countries: Czech Republic, Germany, Europe

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

Sandoz International GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • August 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Generic Drug | Countries: Germany, India, Argentina, Brazil, Canada, Slovenia, Poland, Austria

GILUPI Nanomedizin - Product Pipeline Analysis, 2014 Update

GILUPI Nanomedizin - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • August 2014
  • 20 pages

Summary GILUPI Nanomedizin (GILUPI) develops and commercializes medical devices for isolating rare cells from blood for diagnosis. It develops a new medical detector which is used in-vivo in a patient's vein for catching rare cells such as tumor cells or fetal cells. GILUPI's products are used in the ...

Industries: Pathology | Countries: Poland, Germany

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.